< Back to previous page
Researcher
Katrijn Boon
- Disciplines:Microbiology not elsewhere classified
Affiliations
- Laboratory of Virology and Chemotherapy (Rega Institute) (Division)
Member
From3 Sep 2019 → Today
Projects
1 - 1 of 1
- Development and application of NanoBRET-based technology: Unravelling signalling bias at the human chemokine receptors CXCR1 and CXCR2From3 Sep 2019 → 7 May 2024Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 8 of 8
- Biased antagonism of a series of bicyclic CXCR2 intracellular allosteric modulators(2025)Published in: Frontiers in PharmacologyISSN: 1663-9812Volume: 16
- Development and application of NanoBRET-based technology: Unravelling signalling bias at the human chemokine receptors CXCR1 and CXCR2(2024)
- Systematic Assessment of Human CCR7 Signalling Using NanoBRET Biosensors Points towards the Importance of the Cellular Context(2024)Published in: BiosensorsISSN: 1873-4219Issue: 3Volume: 14
- Systematic assessment of chemokine ligand bias at the human chemokine receptor CXCR2 indicates G protein bias over β-arrestin recruitment and receptor internalization(2024)Published in: Cell Communication and SignalingISSN: 1478-811XIssue: 1Volume: 22
- REGA-SIGN: Development of a Novel Set of NanoBRET-Based G Protein Biosensors(2023)Published in: BiosensorsISSN: 2079-6374Issue: 8Volume: 13
- Exploration of Pyrido[3,4-d]pyrimidines as Antagonists of the Human Chemokine Receptor CXCR2(2023)Published in: MoleculesISSN: 1420-3049Issue: 5Volume: 28
- Cellular Electrical Impedance as a Method to Decipher CCR7 Signalling and Biased Agonism(2022)Published in: International Journal of Molecular SciencesISSN: 1661-6596Issue: 16Volume: 23
- Identification of novel chemotypes as CXCR2 antagonists via a scaffold hopping approach from a thiazolo[5,4-d]pyrimidine(2022)Published in: European Journal of Medicinal ChemistryISSN: 0223-5234Volume: 235